Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of NCOR2 mRNA | affects expression | 21346803
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of NCOR2 mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of NCOR2 mRNA | affects expression | 17562736
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone inhibits the reaction [NCOR2 protein binds to KLK3 promoter] | affects binding|decreases reaction | 16648561
|
D013196 |
Dihydrotestosterone |
methylselenic acid inhibits the reaction [Dihydrotestosterone inhibits the reaction [NCOR2 protein binds to KLK3 promoter]] | affects binding|decreases reaction | 16648561
|
D013196 |
Dihydrotestosterone |
NCOR2 protein inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein] | affects binding|decreases reaction|increases activity | 17804755
|
C061133 |
Am 80 |
Am 80 results in increased expression of NCOR2 mRNA | increases expression | 17229644
|
D015761 |
4-Aminopyridine |
[Bicuculline co-treated with 4-Aminopyridine] affects the localization of NCOR2 protein | affects cotreatment|affects localization | 15773917
|
D015761 |
4-Aminopyridine |
KN 62 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] affects the localization of NCOR2 protein] | affects cotreatment|affects localization|decreases reaction | 15773917
|
D015761 |
4-Aminopyridine |
PD 98059 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] affects the localization of NCOR2 protein] | affects cotreatment|affects localization|decreases reaction | 15773917
|
D015761 |
4-Aminopyridine |
STO 609 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] affects the localization of NCOR2 protein] | affects cotreatment|affects localization|decreases reaction | 15773917
|
C015001 |
arsenite |
arsenite results in increased expression of NCOR2 mRNA | increases expression | 18191166
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased stability of and results in increased expression of NCOR2 protein | increases expression|increases stability | 15857753
|
C053541 |
bicalutamide |
bicalutamide promotes the reaction [AR protein binds to NCOR2 protein] | affects binding|increases reaction | 11981028
|
D001640 |
Bicuculline |
[Bicuculline co-treated with 4-Aminopyridine] affects the localization of NCOR2 protein | affects cotreatment|affects localization | 15773917
|
D001640 |
Bicuculline |
KN 62 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] affects the localization of NCOR2 protein] | affects cotreatment|affects localization|decreases reaction | 15773917
|
D001640 |
Bicuculline |
PD 98059 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] affects the localization of NCOR2 protein] | affects cotreatment|affects localization|decreases reaction | 15773917
|
D001640 |
Bicuculline |
STO 609 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] affects the localization of NCOR2 protein] | affects cotreatment|affects localization|decreases reaction | 15773917
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of NCOR2 protein | increases expression | 18653720
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of NCOR2 mRNA | increases expression | 15336504
|
D004958 |
Estradiol |
Estradiol promotes the reaction [NCOR2 protein binds to TFF1 promoter] | affects binding|increases reaction | 19698761
|
D004958 |
Estradiol |
Estradiol results in decreased expression of NCOR2 mRNA | decreases expression | 19432593
|
D004958 |
Estradiol |
Estradiol results in increased expression of NCOR2 mRNA | increases expression | 20406620
|
D004958 |
Estradiol |
Tamoxifen inhibits the reaction [Estradiol results in increased expression of NCOR2 mRNA] | decreases reaction|increases expression | 20406620
|
D004958 |
Estradiol |
U 0126 promotes the reaction [Tamoxifen inhibits the reaction [Estradiol results in increased expression of NCOR2 mRNA]] | decreases reaction|increases expression|increases reaction | 20406620
|
D004958 |
Estradiol |
Estradiol affects the expression of NCOR2 mRNA | affects expression | 15598610
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of NCOR2 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of NCOR2 mRNA | affects expression | 17351261
|
C063302 |
KN 62 |
KN 62 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] affects the localization of NCOR2 protein] | affects cotreatment|affects localization|decreases reaction | 15773917
|
C008493 |
methylselenic acid |
methylselenic acid inhibits the reaction [Dihydrotestosterone inhibits the reaction [NCOR2 protein binds to KLK3 promoter]] | affects binding|decreases reaction | 16648561
|
C044361 |
M-VAC protocol |
NCOR2 protein results in decreased susceptibility to M-VAC protocol | decreases response to substance | 15814643
|
D019319 |
Okadaic Acid |
Okadaic Acid affects the localization of NCOR2 protein | affects localization | 15773917
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] affects the localization of NCOR2 protein] | affects cotreatment|affects localization|decreases reaction | 15773917
|
D020849 |
Raloxifene |
Raloxifene inhibits the reaction [NCOR2 protein binds to IGF1 promoter] | affects binding|decreases reaction | 17872375
|
D020849 |
Raloxifene |
Raloxifene inhibits the reaction [NCOR2 protein binds to PTGS2 promoter] | affects binding|decreases reaction | 17872375
|
D020849 |
Raloxifene |
Raloxifene results in decreased expression of NCOR2 mRNA | decreases expression | 19432593
|
C458525 |
STO 609 |
STO 609 inhibits the reaction [[Bicuculline co-treated with 4-Aminopyridine] affects the localization of NCOR2 protein] | affects cotreatment|affects localization|decreases reaction | 15773917
|
D013629 |
Tamoxifen |
BRCA1 protein affects the reaction [Tamoxifen promotes the reaction [ESR1 protein binds to NCOR2 protein]] | affects binding|affects reaction|increases reaction | 18997820
|
D013629 |
Tamoxifen |
BRCA1 protein affects the reaction [Tamoxifen promotes the reaction [NCOR2 protein binds to CCND1 promoter]] | affects binding|affects reaction|increases reaction | 18997820
|
D013629 |
Tamoxifen |
NCOR2 protein inhibits the reaction [Tamoxifen results in increased activity of ESR1 protein] | decreases reaction|increases activity | 20406620
|
D013629 |
Tamoxifen |
Tamoxifen inhibits the reaction [Estradiol results in increased expression of NCOR2 mRNA] | decreases reaction|increases expression | 20406620
|
D013629 |
Tamoxifen |
Tamoxifen promotes the reaction [ESR1 protein binds to NCOR2 protein] | affects binding|increases reaction | 18997820
|
D013629 |
Tamoxifen |
Tamoxifen promotes the reaction [NCOR2 protein binds to CCND1 promoter] | affects binding|increases reaction | 18997820
|
D013629 |
Tamoxifen |
Tamoxifen promotes the reaction [NCOR2 protein binds to PGR promoter] | affects binding|increases reaction | 20406620
|
D013629 |
Tamoxifen |
Tamoxifen promotes the reaction [NCOR2 protein binds to TFF1 promoter] | affects binding|increases reaction | 20406620
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased expression of NCOR2 mRNA | decreases expression | 19432593
|
D013629 |
Tamoxifen |
U 0126 promotes the reaction [Tamoxifen inhibits the reaction [Estradiol results in increased expression of NCOR2 mRNA]] | decreases reaction|increases expression|increases reaction | 20406620
|
D013629 |
Tamoxifen |
U 0126 promotes the reaction [Tamoxifen promotes the reaction [NCOR2 protein binds to PGR promoter]] | affects binding|increases reaction | 20406620
|
D013629 |
Tamoxifen |
U 0126 promotes the reaction [Tamoxifen promotes the reaction [NCOR2 protein binds to TFF1 promoter]] | affects binding|increases reaction | 20406620
|
D013749 |
Tetrachlorodibenzodioxin |
NCOR2 protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] | decreases reaction|increases expression | 12139968
|
D013749 |
Tetrachlorodibenzodioxin |
NCOR2 protein promotes the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein results in increased expression of CYP1A1 mRNA]] | increases expression|increases reaction | 12139968
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to NCOR2 protein] | affects binding|increases reaction | 12139968
|
C012589 |
trichostatin A |
trichostatin A affects the localization of NCOR2 protein | affects localization | 15773917
|
C113580 |
U 0126 |
U 0126 promotes the reaction [NCOR2 protein binds to ESR1 protein] | affects binding|increases reaction | 20406620
|
C113580 |
U 0126 |
[U 0126 promotes the reaction [NCOR2 protein binds to ESR1 protein]] which results in decreased activity of ESR1 protein | affects binding|decreases activity|increases reaction | 20406620
|
C113580 |
U 0126 |
U 0126 promotes the reaction [Tamoxifen inhibits the reaction [Estradiol results in increased expression of NCOR2 mRNA]] | decreases reaction|increases expression|increases reaction | 20406620
|
C113580 |
U 0126 |
U 0126 promotes the reaction [Tamoxifen promotes the reaction [NCOR2 protein binds to PGR promoter]] | affects binding|increases reaction | 20406620
|
C113580 |
U 0126 |
U 0126 promotes the reaction [Tamoxifen promotes the reaction [NCOR2 protein binds to TFF1 promoter]] | affects binding|increases reaction | 20406620
|
C113580 |
U 0126 |
U 0126 results in decreased expression of NCOR2 mRNA | decreases expression | 20406620
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.35 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
7.84 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.84 | 14514962 15322242 11752688 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.75 | 17505938 |
MESH:D000168 |
Acrocephalosyndactylia |
|
U 0126 |
5.28 | 17694057 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.05 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.05 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.19 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.41 | 17451421 17308373 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.50 | 15800139 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.78 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.65 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.28 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.55 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Am 80 |
3.71 | 16819260 |
MESH:D050197 |
Atherosclerosis |
|
Am 80 |
4.23 | 16484594 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.44 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.87 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.60 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.64 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.69 | 11985600 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.29 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.27 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.27 | 16675129 17289903 14630087 12948864 17018787 17261762 18497071 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.27 | 15572757 17261762 17893378 17595753 16912660 15758505 17049068 17952589 17242785 17440819 15775269 16837676 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.27 | 16273361 20859285 20065188 11161223 16818667 16202921 19288272 19221464 17261762 19189212 19289846 21152245 18821012 19142967 18997820 15668708 20005174 15565566 18425577 18815881 19487384 19189210 17440819 19084267 17049068 16873071 19066611 20135344 18351453 20544844 19244106 19155303 21138602 19011961 20390343 19115204 18855134 18629630 17242785 17893378 19103187 19200415 19410462 18984771 19059307 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.27 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.27 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.65 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.32 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.29 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
6.29 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
6.29 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
6.29 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.80 | 17123778 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
8.94 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
8.94 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.26 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.31 | 15775269 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
7.05 | 14694615 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.05 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.23 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.23 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.00 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.73 | 16919318 17333356 17681005 11677210 16105132 15861022 17110522 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.03 | 16354765 15668235 15340226 12621046 8697196 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.43 | 15800139 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
2.56 | 15037631 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
8.65 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
8.65 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 10048152 20055451 15322242 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.83 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.17 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.00 | 17474826 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.62 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
14.09 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
14.09 | 15920148 17451421 17308373 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
14.09 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
8.49 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
8.49 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
8.49 | 19085960 19416960 14550746 18071297 11743745 16227642 19164858 17522070 12392966 14725611 16177239 16109766 12594235 16081117 10774834 11461765 11739529 12153990 16393943 12705907 16485898 16781746 18713872 11834606 11529661 10915739 17562736 19739265 19370779 11421492 15968718 10663392 19923254 12958197 12540782 11287661 2444490 17906064 19420014 14986274 15619225 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.49 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.91 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.62 | 11462148 |
MESH:D004487 |
Edema |
|
Raloxifene |
6.29 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.29 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.71 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Am 80 |
20.48 | 16819260 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
20.48 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
20.48 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
20.48 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
5.45 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.98 | 11473722 19148513 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
6.98 | 16202921 19155303 17893378 20544844 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.86 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.87 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
17.40 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
17.40 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
17.40 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
17.40 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.12 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.27 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.34 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.99 | 19069698 |
MESH:D005355 |
Fibrosis |
|
arsenite |
8.19 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.19 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.48 | 16983495 |
MESH:D005909 |
Glioblastoma |
|
Okadaic Acid |
7.61 | 17312396 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
7.61 | 18801729 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.40 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.23 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.40 | 11110106 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.16 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.71 | 12621046 16120746 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.84 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.56 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.85 | 8697196 15340226 18606429 16354765 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.55 | 16870215 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
4.99 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.99 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.62 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.28 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.36 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
4.56 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.56 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.03 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.03 | 16393666 16627594 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.52 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.52 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
11.51 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.51 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
11.51 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.32 | 16973256 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
PD 98059 |
11.45 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
U 0126 |
11.45 | 16972261 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
2.87 | 18206229 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Am 80 |
4.52 | 16531727 16819260 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.02 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
3.32 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.30 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.30 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.30 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.59 | 12969438 16611625 19014921 16610002 19784758 11587558 19460945 12587719 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.07 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
6.96 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
6.96 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
6.96 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
5.34 | 2876786 6135515 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.34 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
3.32 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
3.32 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.32 | 19555203 11884234 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.57 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.57 | 17203775 16891317 11408345 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
5.57 | 11731420 19196723 14580682 16827153 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
12.00 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
12.00 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.48 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
3.48 | 16505122 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.99 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.38 | 19513568 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.36 | 15863610 |
MESH:D009101 |
Multiple Myeloma |
|
Am 80 |
11.66 | 17229644 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
11.66 | 16497877 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
11.66 | 18172295 |
MESH:D009103 |
Multiple Sclerosis |
|
4-Aminopyridine |
5.43 | 19915712 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.87 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.13 | 16810080 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.36 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.67 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.47 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.45 | 19410462 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.81 | 19196722 19189210 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
9.51 | 15738583 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
9.51 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
15.29 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
15.29 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.29 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.72 | 18514411 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.58 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
8.58 | 14694615 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.28 | 19059307 17882678 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.05 | 17823083 15579764 15758505 17893378 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.80 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.76 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
7.76 | 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
U 0126 |
7.76 | 16211241 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.24 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
3.22 | 19294695 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.51 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.06 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.37 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
8.87 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.87 | 11118676 11896295 11399792 11222880 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
5.06 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.98 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.98 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Am 80 |
2.42 | 16289102 |
MESH:D011471 |
Prostatic Neoplasms |
|
bicalutamide |
2.42 | 19240160 19011039 17914592 15638997 18487222 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.42 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.42 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
2.42 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.42 | 16536755 15731164 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.42 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
2.42 | 18798265 19789329 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.12 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
|
Am 80 |
4.02 | 16819260 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.59 | 10548101 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.36 | 15770314 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.65 | 18990726 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.41 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Okadaic Acid |
9.13 | 12628509 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
9.13 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.13 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.92 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.92 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.85 | 19457130 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.67 | 16837676 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.79 | 16045194 16684133 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.44 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.99 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.71 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
13.07 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
13.07 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
7.92 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
7.92 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
7.92 | 17572228 16712894 8653321 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.00 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
M-VAC protocol |
12.00 | 17933135 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.80 | 10982225 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.82 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.12 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.40 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.02 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.37 | 14671159 15869587 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.36 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.06 | 15886252 |